Tirzepatide once weekly for treatment of obesity in patients with type 2 diabetes
study056
10.1016/S0140-6736(23)01200-X
The Lancet
randomized clinical trial
SURMOUNT-2 examined tirzepatide for obesity in adults with type 2 diabetes.
Substantial and clinically meaningful body-weight reduction was observed.
tirzepatide
fat-loss|diabetes
advanced-metabolic-stack
semaglutide-vs-tirzepatide
published